Letrozole functions as an aromatase inhibitor for managing hormone-sensitive breast cancer. Reducing estrogen production limits the hormones that can cause tumor growth in the affected tissue.
When hormone-driven breast cancer needs a different approach, a drug that lowers estrogen production can be part of the plan. Letrozole belongs to a class called aromatase inhibitors, which work by slowing the body’s creation of estrogen. Lowering estrogen helps slow the growth of cancers that rely on this hormone. In Singapore, this active compound can be found in medicines such as Femara.
If you look at the label of Femara, you will see that letrozole is the key ingredient delivering its effect. The drug is sold as a tablet that patients usually take once a day, though other forms such as oral solutions are sometimes available in research settings. In Singapore, both the brand-named Femara and its generic equivalents contain the same letrozole molecule, so the therapeutic intent remains consistent across different product names.
When estrogen-dependent breast cancer is diagnosed after menopause, letrozole may be offered to help manage the disease. The medication is also used in some cases of early-stage breast cancer to reduce the chance of recurrence after surgery. In certain scenarios, doctors may add letrozole after chemotherapy to keep the tumor from growing again. Patients with hormone-sensitive tumors often form the primary group benefiting from this treatment option.
Rather than blocking estrogen directly, letrozole interferes with an enzyme called aromatase that the body uses to make estrogen from other hormones. By curbing this enzyme’s activity, the drug reduces overall estrogen levels in the bloodstream. The lower estrogen environment can make hormone-sensitive cancer cells grow more slowly or stop growing altogether.
Mild symptoms such as joint aches, hot flashes, fatigue, or mild nausea are often reported by people taking letrozole-containing products. These effects usually appear early in treatment and may lessen with time.
Rare but important warning signs include sudden sharp chest pain, severe shortness of breath, or signs of a blood clot such as swelling in the leg. If any of these occur, immediate medical attention is needed.
Letrozole should be avoided by individuals who are pregnant, planning to become pregnant, or who have a known allergy to aromatase inhibitors. Patients with severe liver problems may also need to discuss alternatives with their health team.
Alcohol can increase the feeling of fatigue, and certain medicines that affect liver enzymes might change letrozole levels. Always read the medication’s package insert for a full list of possible interactions.
If you store Femara tablets, keep them in a cool, dry place away from direct sunlight, just as the label advises. Treatment duration can vary, with some patients using letrozole for several years under careful monitoring, while others may have shorter courses. Different letrozole medications may have slight variations in tablet size or packaging, but the active ingredient remains the same. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of letrozole and is not a substitute for professional medical advice. Medicines that contain this ingredient, such as Femara, may differ in formulation, strength, and specific directions for use. The information presented does not create any liability for clinical decisions. Readers should review the labeling of their particular medication and seek guidance from a qualified healthcare professional.
For more detailed reading, consider the following resources:
